Notices. Notice
300 words·~1 min read·
/register/2021/05/10/2021-09811·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4184-45-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2020-N-2030; FDA-2017-N-4951; FDA-2017-N-5569; FDA-2020-N-1652; FDA-2017-N-7012; and FDA-2019-N-4763] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995 (PRA). FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the PRA (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Applications for FDA Approval to Market a New Drug 0910-0001 3/31/2024 Medical Devices; Humanitarian Use Devices 0910-0332 3/31/2024 Medical Devices; Device Tracking 0910-0442 3/31/2024 Dispute Resolution Procedures for Science Based Decision on Products Regulated by CVM 0910-0566 3/31/2024 Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics 0910-0850 3/31/2024 Assessment of Terms and Phrases Commonly Used in Prescription Drug Promotion 0910-0895 3/31/2024 Dated: May 4, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2021-09811 Filed 5-7-21; 8:45 am]
Connectionstraces to 1
Traces to 1 document